Scholarlink

Objective <p>Depression and anxiety are common among people living with HIV (PLHIV), leading to poor quality of life and reduced adherence to antiretroviral therapy (ART). Evidence from Sri Lanka is limited. This study aimed to assess the prevalence and correlates of depression and anxiety among Sinhala speaking PLHIV receiving ART at the National STD/AIDS Control Programme, Colombo.</p> Results <p>A cross sectional study of 320 PLHIV used the validated Sinhala Hospital Anxiety and Depression Scale (HADS-S) and diagnostic interviews. Anxiety prevalence was 27.5% and depression 33.4%. Univariate analyses showed significant associations with female gender (anxiety <i>p</i> = 0.009; depression <i>p</i> &lt; 0.001), low income (anxiety <i>p</i> = 0.005; depression <i>p</i> &lt; 0.001), semi-urban residence (anxiety <i>p</i> = 0.003; depression <i>p</i> = 0.001), sexual minority/transgender identity (anxiety <i>p</i> &lt; 0.001), sexual dysfunction (anxiety <i>p</i> = 0.001; depression <i>p</i> &lt; 0.001), poor ART adherence (anxiety <i>p</i> &lt; 0.001), marital status (anxiety <i>p</i> = 0.016; depression <i>p</i> &lt; 0.001), non-disclosure (anxiety <i>p</i> = 0.008; depression <i>p</i> &lt; 0.001), and suicidality (both <i>p</i> &lt; 0.001). In multivariate regression, poor ART adherence predicted anxiety (OR = 16.45, 95% CI 6.48–41.75). Predictors of depression were HIV awareness &gt; 1 year (OR = 10.10, 95% CI 1.16–87.76), female gender (OR = 3.32, 95% CI 1.42–7.77), marital status (married vs other, OR = 4.95, 95% CI 1.89–12.98), and income ≤ Rs.50,000 (OR = 2.74, 95% CI 1.35–5.56). Anxiety and depression correlated moderately (r = 0.319, <i>p</i> &lt; 0.001). Only 8.1% received antidepressants despite 21.3% reporting suicidality.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Depression and anxiety among people living with HIV on antiretroviral therapy: prevalence and correlates at the National Sexually Transmitted Diseases/AIDS programme, in Sri Lanka

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月21日

查看全文
  • Lahiru Yasas Akuratiyage,
  • Pushpa De Silva,
  • Kumari Nirupama Karunarathna,
  • Geethani Samaraweera,
  • Sithum Manjika,
  • Pubudu Upekshana Chulasiri,
  • Chathurie Uththarika Suraweera

摘要

Objective

Depression and anxiety are common among people living with HIV (PLHIV), leading to poor quality of life and reduced adherence to antiretroviral therapy (ART). Evidence from Sri Lanka is limited. This study aimed to assess the prevalence and correlates of depression and anxiety among Sinhala speaking PLHIV receiving ART at the National STD/AIDS Control Programme, Colombo.

Results

A cross sectional study of 320 PLHIV used the validated Sinhala Hospital Anxiety and Depression Scale (HADS-S) and diagnostic interviews. Anxiety prevalence was 27.5% and depression 33.4%. Univariate analyses showed significant associations with female gender (anxiety p = 0.009; depression p < 0.001), low income (anxiety p = 0.005; depression p < 0.001), semi-urban residence (anxiety p = 0.003; depression p = 0.001), sexual minority/transgender identity (anxiety p < 0.001), sexual dysfunction (anxiety p = 0.001; depression p < 0.001), poor ART adherence (anxiety p < 0.001), marital status (anxiety p = 0.016; depression p < 0.001), non-disclosure (anxiety p = 0.008; depression p < 0.001), and suicidality (both p < 0.001). In multivariate regression, poor ART adherence predicted anxiety (OR = 16.45, 95% CI 6.48–41.75). Predictors of depression were HIV awareness > 1 year (OR = 10.10, 95% CI 1.16–87.76), female gender (OR = 3.32, 95% CI 1.42–7.77), marital status (married vs other, OR = 4.95, 95% CI 1.89–12.98), and income ≤ Rs.50,000 (OR = 2.74, 95% CI 1.35–5.56). Anxiety and depression correlated moderately (r = 0.319, p < 0.001). Only 8.1% received antidepressants despite 21.3% reporting suicidality.